{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:18:11Z","timestamp":1787901491556,"version":"build-2784847793"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Ethics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Opioid diversion\u2014the unauthorized redirection of prescription opioids\u2014is a growing global concern with significant public health implications. While diversion can occur at many points in the supply chain, instances involving healthcare professionals (HCPs) are particularly complex, as they often occur within clinical settings and most often involve self-medication, substance use disorders among healthcare professionals, or peer dynamics. These cases raise not only legal and professional concerns but also profound ethical dilemmas. To date, the ethical perspectives of HCPs in relation to opioid diversion have been underexplored. This multinational qualitative study aims to investigate how HCPs experience and navigate ethical conflicts related to opioid diversion in clinical contexts. The study focuses on the lived experiences and moral reasoning of HCPs who encounter diversion, either among colleagues or in relation to their own practice. It seeks to explore and identify barriers to seeking help and accessing harm reduction, and to understand how these challenges vary across different healthcare systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Semi-structured interviews will be conducted with HCPs working in clinical settings where opioids are used. A fictional scenario involving suspected diversion among peers will be used to encourage reflective discussion. This approach is intended to minimize social desirability bias and potential legal concerns in comparison to assessing experienced diversion. The interview guide is structured around the five steps of ethical analysis as outlined by Marckmann, supporting a theory-informed exploration of individual and systemic dilemmas. Data will be analyzed using reflexive thematic analysis (RTA), allowing for nuanced insights into both explicit reasoning and latent moral constructs. Recruitment of HCPs takes place in hospital departments characterized by frequent opioid use. The study protocol is intended for international implementation to support cross-national comparative analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study will generate a deeper understanding of the ethical tensions HCPs face in the context of opioid diversion. By identifying structural and cultural drivers behind moral distress, the findings may help address stigma and inform the development of ethically guided harm reduction strategies as well as supportive structures for HCPs. The cross-national comparative perspective aims to contribute to an international framework for reducing opioid-related harm in healthcare.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12910-026-01581-6","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:34:16Z","timestamp":1787898856000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["On the blind spot: ethical conflicts of health care professionals in addressing opioid diversion - a template study protocol for multinational qualitative research"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4253-3177","authenticated-orcid":false,"given":"Annette","family":"Binder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Mathes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"1581_CR1","doi-asserted-by":"publisher","first-page":"104665","DOI":"10.1016\/j.drugpo.2024.104665","volume":"135","author":"L Martignetti","year":"2025","unstructured":"Martignetti L, Knight R, Nafeh F, Atkinson K, Laurence G, Johnson CH, et al. Motivations for and perspectives of medication diversion among clients of a safer opioid supply program in Toronto, Canada. Int J Drug Policy. 2025;135:104665.","journal-title":"Int J Drug Policy"},{"issue":"12","key":"1581_CR2","doi-asserted-by":"publisher","first-page":"e2451988","DOI":"10.1001\/jamanetworkopen.2024.51988","volume":"7","author":"M Olding","year":"2024","unstructured":"Olding M, Rudzinski K, Schmidt R, Kolla G, German D, Sereda A, et al. Perspectives on diversion of medications from safer opioid supply programs. JAMA Netw Open. 2024;7(12):e2451988\u2013e.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"1581_CR3","doi-asserted-by":"publisher","first-page":"e0256741","DOI":"10.1371\/journal.pone.0256741","volume":"16","author":"K Sundararajan","year":"2021","unstructured":"Sundararajan K, Ajrawat P, Canizares M, Power JD, Perruccio AV, Sarro A, et al. The potential for diversion of prescribed opioids among orthopaedic patients: Results of an anonymous patient survey. PLoS ONE. 2021;16(8):e0256741.","journal-title":"PLoS ONE"},{"issue":"4","key":"1581_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jpainsymman.2020.09.013","volume":"61","author":"OD Ware","year":"2021","unstructured":"Ware OD, Cagle JG, McPherson ML, Sacco P, Frey J, Guralnik J. Confirmed medication diversion in hospice care: qualitative findings from a national sample of agencies. J Pain Symptom Manag. 2021;61(4):789\u201396.","journal-title":"J Pain Symptom Manag"},{"key":"1581_CR5","doi-asserted-by":"crossref","unstructured":"Berge KH, Dillon KR, Sikkink KM, Taylor TK, Lanier WL, editors. Diversion of drugs within health care facilities, a multiple-victim crime: patterns of diversion, scope, consequences, detection, and prevention. Mayo Clinic Proceedings; 2012: Elsevier.","DOI":"10.1016\/j.mayocp.2012.03.013"},{"issue":"4","key":"1581_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.apergo.2006.04.011","volume":"37","author":"P Carayon","year":"2006","unstructured":"Carayon P. Human factors of complex sociotechnical systems. Appl Ergon. 2006;37(4):525\u201335.","journal-title":"Appl Ergon"},{"issue":"3","key":"1581_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/practneurol-2017-001740","volume":"18","author":"DY Tan","year":"2018","unstructured":"Tan DY, Ter Meulen BC, Molewijk A, Widdershoven G. Moral case deliberation. Pract Neurol. 2018;18(3):181\u20136.","journal-title":"Pract Neurol"},{"issue":"2","key":"1581_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qualitative Res Psychol"},{"issue":"6","key":"1581_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"issue":"6","key":"1581_CR10","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1177\/02692163241234800","volume":"38","author":"V Braun","year":"2024","unstructured":"Braun V, Clarke V. Supporting best practice in reflexive thematic analysis reporting in Palliative Medicine: A review of published research and introduction to the Reflexive Thematic Analysis Reporting Guidelines (RTARG). Palliat Med. 2024;38(6):608\u201316.","journal-title":"Palliat Med"},{"issue":"2","key":"1581_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00481-013-0252-x","volume":"25","author":"G Marckmann","year":"2013","unstructured":"Marckmann G. Wann ist eine ethische Analyse eine gute ethische Analyse? Ein Pl\u00e4doyer f\u00fcr die Methodenreflexion in der Medizinethik. Ethik der Medizin. 2013;25(2):87\u20138.","journal-title":"Ethik der Medizin"},{"issue":"13","key":"1581_CR12","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1177\/1049732315617444","volume":"26","author":"K Malterud","year":"2016","unstructured":"Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: guided by information power. Qual Health Res. 2016;26(13):1753\u201360.","journal-title":"Qual Health Res"},{"key":"1581_CR13","doi-asserted-by":"crossref","unstructured":"Braun V, Clarke V. Thematic analysis: A practical guide. SAGE; 2021.","DOI":"10.4135\/9781036232078.n9"},{"issue":"2","key":"1581_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1515\/zfsoz-2018-1006","volume":"47","author":"J Str\u00fcbing","year":"2018","unstructured":"Str\u00fcbing J, Hirschauer S, Aya\u00df R, Kr\u00e4hnke U, Scheffer T. G\u00fctekriterien qualitativer sozialforschung. Ein diskussionsansto\u00df. Z f\u00fcr Soziologie. 2018;47(2):83\u2013100.","journal-title":"Z f\u00fcr Soziologie"},{"key":"1581_CR15","unstructured":"Deppermann A, Lucius-Hoene G. Rekonstruktion narrativer Identit\u00e4t: ein Arbeitsbuch Zur analyse narrativer interviews. Springer-; 2013."},{"issue":"6","key":"1581_CR16","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.pec.2021.10.016","volume":"105","author":"AF Hannawa","year":"2022","unstructured":"Hannawa AF, Wu AW, Kolyada A, Potemkina A, Donaldson LJ. The aspects of healthcare quality that are important to health professionals and patients: A qualitative study. Patient Educ Couns. 2022;105(6):1561\u201370.","journal-title":"Patient Educ Couns"},{"key":"1581_CR17","unstructured":"International Narcotics Control Board. Report of the International Narcotics Control Board for 2017 (pp. 104\u2013106.). In: Nations U, editor. 2018."},{"issue":"4","key":"1581_CR18","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1177\/0098858820975533","volume":"46","author":"RR Rousseau","year":"2020","unstructured":"Rousseau RR. Drug diversion in the health care system: cultural change via legal and policy mechanisms. Am J Law Med. 2020;46(4):446\u201368.","journal-title":"Am J Law Med"},{"key":"1581_CR19","unstructured":"Central University Research Ethics Committee (CUREC). Handling Distress or Mental Health Problems in Participants in CUREC-Approved Research, Best Practice Guidance 08_Version 2.0. University of Oxford; 2023."}],"container-title":["BMC Medical Ethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12910-026-01581-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12910-026-01581-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12910-026-01581-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:50:19Z","timestamp":1787899819000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12910-026-01581-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1581"],"URL":"https:\/\/doi.org\/10.1186\/s12910-026-01581-6","relation":{},"ISSN":["1472-6939"],"issn-type":[{"value":"1472-6939","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study will be conducted in accordance with the Declaration of Helsinki. The study was approved by the Ethics Committee of the Medical Faculty, University of T\u00fcbingen (Application No. 2025\u2009\u2212\u2009823).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"183"}}